Berger Dietmar 4
4 · Atara Biotherapeutics, Inc. · Filed Mar 27, 2019
Insider Transaction Report
Form 4
Berger Dietmar
Global Head of R&D
Transactions
- Award
Common Stock
2019-03-26+15,000→ 90,000 total
Footnotes (1)
- [F1]These restricted stock units vest as to 50% of the shares on March 26, 2020 and 50% of the shares on March 26, 2021, subject to the reporting person's continuous service.